Ansell Limited (ASX:ANN) Guides FY27 Adjusted EPS to USD 1.58-1.70

Aditi Sarkar

03 October 2026 08:01 PM AEST

Ansell Limited (ASX:ANN) Guides FY27 Adjusted EPS to USD 1.58-1.70

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

• Ansell confirmed an FY26 final Dividend of USD 0.415 per share, equivalent to AUD 0.5788 at the stated exchange rate, payable on 17 September 2026.

• FY27 adjusted EPS guidance is USD 1.58-1.70.

• Ansell Limited operates in protective gloves, clothing and safety solutions for healthcare and industrial customers in more than 100 countries.

• Key areas to watch include FY27 EPS delivery, Volume and pricing, raw-material costs, foreign exchange and the ongoing USD 200mn buyback.

Ansell Limited (ASX:ANN) enters its next reporting phase with a clearly defined operating agenda. The company is focused on protective gloves, clothing and safety solutions for healthcare and industrial customers in more than 100 countries. Its latest company-reported update adds fresh detail on execution, while the stated outlook sets measurable milestones for the period ahead. For readers following ANN, the central question is how those operational targets translate into production, earnings, Cash Flow or project progress through FY27.

Company Business

Ansell Limited is an ASX-listed Business focused on protective gloves, clothing and safety solutions for healthcare and industrial customers in more than 100 countries. This operating base determines the metrics that matter most when assessing progress. For producers and industrial companies, volumes, margins and Capital discipline are central. For financial, healthcare and technology businesses, customer adoption, earnings, capital management and execution of growth initiatives can carry more weight.

The latest company information provides a practical snapshot of where the business currently stands. Ansell confirmed an FY26 final dividend of USD 0.415 per share, equivalent to AUD 0.5788 at the stated exchange rate, payable on 17 September 2026. Its DRP price was set at AUD 41.92 per share. This update forms the immediate operating backdrop for the next stage of the company’s program.

The 2026 Work Program Takes Shape

The outlook now provides a more forward-looking framework. FY27 adjusted EPS guidance is USD 1.58-1.70. Ansell assumes constant-currency sales growth from higher volumes and price, an approximately USD 9mn EBIT foreign-exchange tailwind, capex of USD 45-55mn and net interest of around USD 43mn. These targets give investors specific markers against which subsequent company updates can be assessed.

Execution will matter as much as the headline guidance. Companies can meet strategic objectives only by coordinating operations, capital allocation, workforce, customers, suppliers and project schedules. For Ansell Limited, the next reporting periods should therefore show whether the business is moving through its stated milestones at the pace anticipated by management.

Sector Context

The broader healthcare setting can influence demand, pricing and access to capital, but company-specific execution remains important. Ansell Limited operates through protective gloves, clothing and safety solutions for healthcare and industrial customers in more than 100 countries. That means sector conditions should be considered alongside the company’s own cost base, asset quality, Balance Sheet and ability to deliver its operating plan.

Where Commodity exposure is involved, realised prices and currencies can materially change Revenue and margins. Contract and technology businesses can be more sensitive to order conversion, delivery timing and customer adoption. Financial and real-estate businesses also face interest-rate, funding and regulatory considerations. These factors provide context for the company’s stated outlook without replacing the need to track its own reported results.

Risks to Consider

The company’s disclosed risk profile includes raw-material costs, US tariffs, Middle East supply-chain disruption, foreign exchange and macroeconomic conditions across industrial and healthcare markets. These factors can affect earnings, cash generation, project timing or the ability to achieve guidance.

Guidance and outlook statements are inherently forward-looking and may change as operating conditions evolve. Cost inflation, regulatory decisions, project delays, customer behaviour or market conditions can alter the pace of delivery. Readers should therefore compare future updates with the specific production, earnings, capital or operational milestones set out by the company rather than relying on a single reporting period.

What to Watch Next

Attention now turns to FY27 EPS delivery, volume and pricing, raw-material costs, foreign exchange and the ongoing USD 200mn buyback. These are the clearest near-term markers for assessing how Ansell Limited progresses from its latest update into the next phase of FY27 execution.

FAQs

Q: What is Ansell Limited's ASX ticker?

A: Ansell Limited trades on the Australian Securities Exchange under ASX:ANN.

Q: What is the latest business update from Ansell Limited?

A: Ansell confirmed an FY26 final dividend of USD 0.415 per share, equivalent to AUD 0.5788 at the stated exchange rate, payable on 17 September 2026. Its DRP price was set at AUD 41.92 per share.

Q: What is the company's outlook?

A: FY27 adjusted EPS guidance is USD 1.58-1.70. Ansell assumes constant-currency sales growth from higher volumes and price, an approximately USD 9mn EBIT foreign-exchange tailwind, capex of USD 45-55mn and net interest of around USD 43mn.

Q: What should readers watch next for ANN?

A: Key areas include FY27 EPS delivery, volume and pricing, raw-material costs, foreign exchange and the ongoing USD 200mn buyback.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.